1. The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview;Baccarani;Leukemia,2019
2. Performance characteristics of the first food and drug administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia;Shelton;PLoS One,2022
3. Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib;Chen;Nan Fang Yi Ke Da Xue Xue Bao,2019
4. T315I-mutated myeloid sarcoma;Zhang;Leuk Res Rep,2019
5. Mechanistic insights into co-administration of allosteric and orthosteric drugs to overcome drug-resistance in T315I BCR-ABL1;Zhang;Front Pharmacol,2022